Francesco Panzuto

Pubblicazioni

Titolo Pubblicato in Anno
A Case Report of Multiple Gastrointestinal Stromal Tumors: Imaging Findings, Surgical Approach, and Review of the Literature FRONTIERS IN SURGERY 2022
Effect of Neuroendocrine Neoplasm Treatment on Human Reproductive Health and Sexual Function JOURNAL OF CLINICAL MEDICINE 2022
CT-based radiomics for prediction of therapeutic response to Everolimus in metastatic neuroendocrine tumors LA RADIOLOGIA MEDICA 2022
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial BRITISH JOURNAL OF SURGERY 2022
What gastroenterologists should know about carcinoid syndrome GASTROENTEROLOGY INSIGHTS 2022
The Antiproliferative Activity of High-Dose Somatostatin Analogs in Gastro-Entero-Pancreatic Neuroendocrine Tumors. A Systematic Review and Meta-Analysis JOURNAL OF CLINICAL MEDICINE 2022
Nuclear Medicine and Radiological Imaging of Pancreatic Neuroendocrine Neoplasms: A Multidisciplinary Update JOURNAL OF CLINICAL MEDICINE 2022
Small nonfunctional pancreatic neuroendocrine neoplasms: Time for a step-up treatment approach? ENDOSCOPIC ULTRASOUND 2022
Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series JOURNAL OF CROHN'S AND COLITIS (ONLINE) 2022
Therapy of NET with radiolabeled SST analogs Nuclear Medicine and Molecular Imaging 2022
Il valore aggiunto della RLT: che cosa insegna l’esperienza clinica nei tumori neuroendocrini. La terapia con radioligandi in oncologia 2022
Comparison of Endoscopic Techniques in the Management of Type I Gastric Neuroendocrine Neoplasia: A Systematic Review GASTROENTEROLOGY RESEARCH AND PRACTICE 2021
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: data from a retrospective multi-centric study DIGESTIVE AND LIVER DISEASE 2021
Management of type-I gastric neuroendocrine neoplasms. A 10-years prospective single centre study DIGESTIVE AND LIVER DISEASE 2021
Exocrine pancreatic insufficiency and somatostatin analogs in patients with neuroendocrine neoplasia EXPERT OPINION ON DRUG SAFETY 2021
Efficacy of lutetium-peptide receptor radionuclide therapy in inducing prolonged tumour regression in small-bowel veuroendocrine tumours. A case of favourable response to retreatment after Initial objective response ONCOLOGY RESEARCH AND TREATMENT 2021
Octreotide long-acting release (LAR) in combination with other therapies for treatment of neuroendocrine neoplasia. A systematic review JOURNAL OF GASTROINTESTINAL ONCOLOGY 2021
Tumor heterogenity in gastro-entero-pancreatic neuroendocrine neoplasia ENDOCRINES 2021
Reply to Dr. Hall and coworkers EXPERT OPINION ON DRUG SAFETY 2021
Bone Metastases in Neuroendocrine Tumors. Molecular Pathogenesis and Implications in Clinical Practice NEUROENDOCRINOLOGY 2021

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma